Home

série Čtvrtý Slovo kras marker hierarchie kretén Léčivý

IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past  Efforts to Future Challenges
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges

Analysis of circulating cell-free DNA identifies KRAS copy number gain and  mutation as a novel prognostic marker in Pancreatic cancer | Scientific  Reports
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer | Scientific Reports

Overcoming KRAS-Mutant Lung Cancer | American Society of Clinical Oncology  Educational Book
Overcoming KRAS-Mutant Lung Cancer | American Society of Clinical Oncology Educational Book

Hitting an Elusive Target in Pancreatic Cancer - NCI
Hitting an Elusive Target in Pancreatic Cancer - NCI

KRAS Positive Lung Cancer: Testing and Management
KRAS Positive Lung Cancer: Testing and Management

The Trouble With KRAS - Cancer Commons
The Trouble With KRAS - Cancer Commons

Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The  Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies

KRAS mutations predict response to EGFR inhibitors - ScienceDirect
KRAS mutations predict response to EGFR inhibitors - ScienceDirect

Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future  Perspectives
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives

The improbable targeted therapy: KRAS as an emerging target in non-small  cell lung cancer (NSCLC) - ScienceDirect
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect

Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated  Non-Small-Cell Lung Cancer
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer

Integrated multi-omics characterization of KRAS mutant colorectal cancer
Integrated multi-omics characterization of KRAS mutant colorectal cancer

KRAS(G12D) can be targeted by potent inhibitors via formation of salt  bridge | Cell Discovery
KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge | Cell Discovery

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct  Activating KRAS Mutations | Journal of Proteome Research
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research

Correlation between clinical data and molecular marker alterations in... |  Download Scientific Diagram
Correlation between clinical data and molecular marker alterations in... | Download Scientific Diagram

KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung  Cancer - ScienceDirect
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer - ScienceDirect

Targeting KRAS mutant cancers: from druggable therapy to drug resistance |  Molecular Cancer | Full Text
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text

Immune modulatory effects of oncogenic KRAS in cancer | Nature  Communications
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of  pancreatic cancer | Nature Reviews Gastroenterology & Hepatology
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer | Nature Reviews Gastroenterology & Hepatology

Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer  treatment - ScienceDirect
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect

KRAS-mutant non-small cell lung cancer: Converging small molecules and  immune checkpoint inhibition - eBioMedicine
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine

IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in  Colorectal Cancer
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer

Computational Analysis of KRAS Mutations: Implications for Different  Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE

KRAS - Wikipedia
KRAS - Wikipedia

Molecular epidemiology and diagnostics of KRAS mutations in human cancer |  SpringerLink
Molecular epidemiology and diagnostics of KRAS mutations in human cancer | SpringerLink

Chemically modified MIR143-3p exhibited anti-cancer effects by impairing  the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic  Acids
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids